Simplex Trading’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140K Hold
5,000
﹤0.01% 5158
2026
Q1
$143K Buy
+5,000
New +$171K ﹤0.01% 4684
2024
Q2
Sell
-8,000
Closed -$243K 8737
2024
Q1
$243K Buy
8,000
+7,900
+7,900% +$265K ﹤0.01% 4632
2023
Q4
$3K Buy
+100
New +$3.72K ﹤0.01% 8050
2022
Q4
Sell
-2,100
Closed -$82K 9169
2022
Q3
$82K Buy
+2,100
New +$96.1K ﹤0.01% 5781
2021
Q4
Sell
-200
Closed -$16K 10436
2021
Q3
$16K Hold
200
﹤0.01% 8601
2021
Q2
$15K Buy
200
+198
+9,900% +$14.4K ﹤0.01% 8811
2021
Q1
$13K Buy
+2
New +$123 ﹤0.01% 7737
2020
Q3
Sell
-5
Closed -$22K 7759
2020
Q2
$22K Buy
5
+2
+67% +$87 ﹤0.01% 6133
2020
Q1
$10K Sell
3
-4
-57% -$144 ﹤0.01% 6452
2019
Q4
$22K Sell
7
-146
-95% -$4.16K ﹤0.01% 5864
2019
Q3
$381K Buy
153
+150
+5,000% +$4.28K ﹤0.01% 2899
2019
Q2
$8K Sell
3
-2
-40% -$58 ﹤0.01% 6210
2019
Q1
$13K Buy
+5
New +$152 ﹤0.01% 5977

Other funds holding ATRC

Simplex Trading's ATRC Position: Q2 2026 in Review

Simplex Trading increased its AtriCure (ATRC) stake by 21% in Q2 2026, buying an estimated $14.7K and bringing the position to 3,034 shares worth $84.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5751.

Simplex Trading first reported a position in ATRC in Q2 2017 and has held it in 19 quarters since. The position peaked at $121K in Q1 2024. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Simplex Trading held 3,034 shares of AtriCure worth $84.9K as of Q2 2026.
  • Simplex Trading bought 522 AtriCure shares in Q2 2026, an estimated $14.7K.
  • AtriCure made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5751 holding.
  • Simplex Trading first reported a position in AtriCure in Q2 2017 and has held it in 19 quarters since.
  • Simplex Trading's AtriCure position peaked at $121K in Q1 2024.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.